NOS2 and metabolic dysfunction-associated steatotic liver disease: Chronic NOS inhibition has been reported to accelerate NAFLD progression [8]; however, the roles of eNOS and generated NO in the pathogenesis of NAFLD/NASH have not yet been fully elucidated in eNOS knockout (eNOS-/-) mice fed a high-fat diet (HFD).